MS-related cognitive impairments are often misperceived by others, columnist Desiree Lama writes, which can make a case of ...

The effort will help the company assemble an investigational new drug application for Lucid-MS, which is expected by the end ...

Factors including smoking status and relapse frequency are linked to increased risk of disease progression in MS, a ...

Supervised at-home neural stimulation helped women with MS and cannabis use disorder decrease their cannabis intake and ...

Stem cells from donated placentas appear safe and may help ease secondary progressive MS, a small open-label Phase 1 clinical ...

You should continue taking multiple sclerosis medication even when you feel fine, as stopping can risk worsening symptoms.

Women with MS who have a close friend to confide in have better physical and mental health than those without this kind of ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

Non-pharmacological interventions, such as mindfulness and exercise, may improve sleep for MS patients, a meta-analysis of ...

Three months of supplements with ellagic acid — an antioxidant — significantly eased fatigue, depression, and anxiety in MS ...

The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

The number of mitochondrial DNA copies may drop as MS progresses, suggesting a possible biomarker for disease progression, a ...